Titre : Interventions chirurgicales robotisées

Interventions chirurgicales robotisées : Questions médicales fréquentes

Termes MeSH sélectionnés :

Probability
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Interventions chirurgicales robotisées : Questions médicales les plus fréquentes", "headline": "Interventions chirurgicales robotisées : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Interventions chirurgicales robotisées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-28", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Interventions chirurgicales robotisées" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Automatisation", "url": "https://questionsmedicales.fr/mesh/D001331", "about": { "@type": "MedicalCondition", "name": "Automatisation", "code": { "@type": "MedicalCode", "code": "D001331", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "J01.897.104" } } }, "about": { "@type": "MedicalCondition", "name": "Interventions chirurgicales robotisées", "alternateName": "Robotic Surgical Procedures", "code": { "@type": "MedicalCode", "code": "D065287", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Robert Bergholz", "url": "https://questionsmedicales.fr/author/Robert%20Bergholz", "affiliation": { "@type": "Organization", "name": "Department of General, Visceral, Thoracic, Transplant and Pediatric Surgery, UKSH University Hospital of Schleswig-Holstein Kiel Campus, Arnold-Heller-Strasse 3, 24105 Kiel, Germany." } }, { "@type": "Person", "name": "Ugo Pinar", "url": "https://questionsmedicales.fr/author/Ugo%20Pinar", "affiliation": { "@type": "Organization", "name": "Urology, Predictive Onco-Urology, GRC 5, APHP, Pitié-Salpêtrière, Sorbonne University, 75013, Paris, France." } }, { "@type": "Person", "name": "Morgan Roupret", "url": "https://questionsmedicales.fr/author/Morgan%20Roupret", "affiliation": { "@type": "Organization", "name": "Urology, Predictive Onco-Urology, GRC 5, APHP, Pitié-Salpêtrière, Sorbonne University, 75013, Paris, France. morgan.roupret@aphp.fr." } }, { "@type": "Person", "name": "Ankit Shukla", "url": "https://questionsmedicales.fr/author/Ankit%20Shukla", "affiliation": { "@type": "Organization", "name": "Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India." } }, { "@type": "Person", "name": "Senthil Gnanasekaran", "url": "https://questionsmedicales.fr/author/Senthil%20Gnanasekaran", "affiliation": { "@type": "Organization", "name": "Department of Surgical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.", "datePublished": "2024-05-07", "url": "https://questionsmedicales.fr/article/38774215", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fphar.2024.1336347" } }, { "@type": "ScholarlyArticle", "name": "Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37034700", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/2023.03.24.23287710" } }, { "@type": "ScholarlyArticle", "name": "Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35834254", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2022.20680" } }, { "@type": "ScholarlyArticle", "name": "Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study.", "datePublished": "2024-11-17", "url": "https://questionsmedicales.fr/article/39417364", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.57264/cer-2023-0027" } }, { "@type": "ScholarlyArticle", "name": "Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.", "datePublished": "2023-03-04", "url": "https://questionsmedicales.fr/article/36880088", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/jacamr/dlad011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Technologie, industrie et agriculture", "item": "https://questionsmedicales.fr/mesh/D013676" }, { "@type": "ListItem", "position": 3, "name": "Technologie", "item": "https://questionsmedicales.fr/mesh/D013672" }, { "@type": "ListItem", "position": 4, "name": "Automatisation", "item": "https://questionsmedicales.fr/mesh/D001331" }, { "@type": "ListItem", "position": 5, "name": "Interventions chirurgicales robotisées", "item": "https://questionsmedicales.fr/mesh/D065287" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Interventions chirurgicales robotisées - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Interventions chirurgicales robotisées", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Interventions chirurgicales robotisées", "description": "Comment évaluer l'éligibilité à la chirurgie robotisée ?\nQuels examens préalables sont nécessaires ?\nQuels signes indiquent une chirurgie robotisée ?\nComment diagnostiquer une maladie nécessitant une chirurgie robotisée ?\nQuels spécialistes impliqués dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D065287?mesh_terms=Probability&page=275#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Interventions chirurgicales robotisées", "description": "Quels symptômes nécessitent une intervention robotisée ?\nComment les symptômes varient selon la maladie ?\nLes symptômes sont-ils toujours évidents ?\nQuels symptômes post-opératoires sont normaux ?\nQuand consulter après une chirurgie robotisée ?", "url": "https://questionsmedicales.fr/mesh/D065287?mesh_terms=Probability&page=275#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Interventions chirurgicales robotisées", "description": "Comment prévenir les complications post-opératoires ?\nY a-t-il des mesures préventives avant la chirurgie ?\nComment réduire le risque d'infection après la chirurgie ?\nQuels conseils pour une récupération rapide ?\nLes vaccinations sont-elles importantes avant la chirurgie ?", "url": "https://questionsmedicales.fr/mesh/D065287?mesh_terms=Probability&page=275#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Interventions chirurgicales robotisées", "description": "Quels types de chirurgies sont robotisées ?\nQuels sont les avantages des interventions robotisées ?\nComment se déroule une chirurgie robotisée ?\nQuels sont les risques associés à la chirurgie robotisée ?\nQuelle est la durée typique d'une chirurgie robotisée ?", "url": "https://questionsmedicales.fr/mesh/D065287?mesh_terms=Probability&page=275#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Interventions chirurgicales robotisées", "description": "Quelles sont les complications possibles de la chirurgie robotisée ?\nComment gérer une infection post-opératoire ?\nLes complications sont-elles fréquentes ?\nQuels signes indiquent une complication ?\nComment prévenir les complications chirurgicales ?", "url": "https://questionsmedicales.fr/mesh/D065287?mesh_terms=Probability&page=275#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Interventions chirurgicales robotisées", "description": "Quels facteurs augmentent le risque de complications ?\nLe poids influence-t-il le risque chirurgical ?\nLes antécédents médicaux jouent-ils un rôle ?\nLe tabagisme affecte-t-il la chirurgie robotisée ?\nComment évaluer les facteurs de risque avant la chirurgie ?", "url": "https://questionsmedicales.fr/mesh/D065287?mesh_terms=Probability&page=275#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer l'éligibilité à la chirurgie robotisée ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "L'évaluation inclut l'examen médical, les antécédents et les tests d'imagerie." } }, { "@type": "Question", "name": "Quels examens préalables sont nécessaires ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses sanguines, des échographies et des IRM peuvent être requis." } }, { "@type": "Question", "name": "Quels signes indiquent une chirurgie robotisée ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des indications incluent des tumeurs, des maladies cardiaques ou des problèmes gynécologiques." } }, { "@type": "Question", "name": "Comment diagnostiquer une maladie nécessitant une chirurgie robotisée ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des examens cliniques et des tests d'imagerie ciblés." } }, { "@type": "Question", "name": "Quels spécialistes impliqués dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les chirurgiens, radiologues et oncologues participent au diagnostic." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une intervention robotisée ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs persistantes, des saignements anormaux ou des masses peuvent indiquer une intervention." } }, { "@type": "Question", "name": "Comment les symptômes varient selon la maladie ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes dépendent de la localisation et de la gravité de la maladie." } }, { "@type": "Question", "name": "Les symptômes sont-ils toujours évidents ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains symptômes peuvent être subtils ou confondus avec d'autres conditions." } }, { "@type": "Question", "name": "Quels symptômes post-opératoires sont normaux ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Douleurs légères, fatigue et gonflement sont courants après la chirurgie." } }, { "@type": "Question", "name": "Quand consulter après une chirurgie robotisée ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Consultez si vous ressentez des douleurs intenses, des saignements ou de la fièvre." } }, { "@type": "Question", "name": "Comment prévenir les complications post-opératoires ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Suivez les instructions du médecin, hydratez-vous et évitez les efforts excessifs." } }, { "@type": "Question", "name": "Y a-t-il des mesures préventives avant la chirurgie ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, arrêter de fumer et maintenir un poids santé peuvent aider." } }, { "@type": "Question", "name": "Comment réduire le risque d'infection après la chirurgie ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Maintenez la zone opérée propre et suivez les conseils d'hygiène du médecin." } }, { "@type": "Question", "name": "Quels conseils pour une récupération rapide ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Reposez-vous, suivez un régime équilibré et assistez aux suivis médicaux." } }, { "@type": "Question", "name": "Les vaccinations sont-elles importantes avant la chirurgie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, être à jour sur les vaccinations peut réduire le risque d'infections." } }, { "@type": "Question", "name": "Quels types de chirurgies sont robotisées ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les chirurgies urologiques, gynécologiques et thoraciques sont couramment robotisées." } }, { "@type": "Question", "name": "Quels sont les avantages des interventions robotisées ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Elles offrent une précision accrue, moins de douleur et un temps de récupération réduit." } }, { "@type": "Question", "name": "Comment se déroule une chirurgie robotisée ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le chirurgien contrôle le robot via une console, réalisant des mouvements précis." } }, { "@type": "Question", "name": "Quels sont les risques associés à la chirurgie robotisée ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des infections, des saignements et des complications anesthésiques." } }, { "@type": "Question", "name": "Quelle est la durée typique d'une chirurgie robotisée ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La durée varie, mais elle est généralement de 1 à 4 heures selon la procédure." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de la chirurgie robotisée ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections, des lésions organiques et des saignements." } }, { "@type": "Question", "name": "Comment gérer une infection post-opératoire ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin pour un traitement antibiotique et un suivi approprié." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications sont rares mais peuvent survenir, nécessitant une surveillance." } }, { "@type": "Question", "name": "Quels signes indiquent une complication ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Des douleurs intenses, des rougeurs ou des écoulements anormaux peuvent indiquer une complication." } }, { "@type": "Question", "name": "Comment prévenir les complications chirurgicales ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Suivez les recommandations médicales et signalez tout symptôme inhabituel rapidement." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de complications ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge avancé, les maladies chroniques et le tabagisme augmentent les risques." } }, { "@type": "Question", "name": "Le poids influence-t-il le risque chirurgical ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'obésité peut augmenter le risque de complications pendant et après la chirurgie." } }, { "@type": "Question", "name": "Les antécédents médicaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents de maladies cardiaques ou respiratoires augmentent les risques." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la chirurgie robotisée ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut retarder la guérison et augmenter le risque d'infections." } }, { "@type": "Question", "name": "Comment évaluer les facteurs de risque avant la chirurgie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation complète des antécédents médicaux et des tests de santé est nécessaire." } } ] } ] }

Sources (2752 au total)

Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.

This study aimed to elucidate the therapeutic effects of Huaier granules on hepatocellular carcinoma (HCC) within the Milan criteria in patients who underwent microwave ablation (MWA).... A total of 228 patients were included, with 97 in the Huaier group and 131 in the control group. We evaluated progression-free survival (PFS), overall survival (OS), and extrahepatic metastasis surviv... Following PSM, the 1-, 3-, and 5-year PFS rates in the Huaier and control groups were 83.5% vs 70.7%, 57.7% vs 42.6%, and 43.6% vs 31.9% (... Huaier granules can reduce the risk of recurrence and improve the OS of patients with HCC within the Milan criteria following MWA. Administering Huaier granules for over 6 months proved beneficial....

Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.

Given the limitations of extant models for normal tissue complication probability estimation for osteoradionecrosis (ORN) of the mandible, the purpose of this study was to enrich statistical inference... The analysis was conducted on retrospective data of 1,259 head and neck cancer (HNC) patients treated at the University of Texas MD Anderson Cancer Center between 2005 and 2015. The (structural) clust... The K-means clustering method identified six clusters among the DVHs. Based on the first five clusters, the dose-volume space was partitioned almost perfectly by the soft-margin SVM into distinct regi... This study presents an unsupervised-learning analysis of a large-scale data set to evaluate the risk of mandibular ORN among HNC patients. The results provide a visual risk-assessment tool (based on t...

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

The cardiovascular and renal outcomes of angiotensin-II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatment are well-known; however, few studies have evaluated initiati... To emulate a target trial to evaluate the cognitive outcomes of initiating an ARB- vs ACEI-based antihypertensive regimen in individuals at risk for mild cognitive impairment (MCI) and probable dement... Active comparator, new-user observational cohort study design using data from the Systolic Blood Pressure Intervention Trial (SPRINT), conducted November 2010 through July 2018. Marginal cause-specifi... New users of ARB vs ACEI during the first 12 months of trial follow-up.... Composite of adjudicated amnestic MCI or PD.... Of 9361 participants, 727 and 1313 new users of an ARB or ACEI, respectively, with well-balanced baseline characteristics between medication exposure groups after inverse probability weighting (mean [... In this observational cohort study of US adults at high cardiovascular disease risk, there was no difference in the rate of amnestic MCI or PD among new users of an ARB compared with ACEI, although 95...

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.

To assess the relationship between renal function and efficacy/safety of imipenem/cilastatin/relebactam for the treatment of hospital-acquired/ventilator-associated pneumonia (HABP/VABP) from RESTORE-... Adults with HABP/VABP were randomized 1:1 to IV imipenem/cilastatin/relebactam 1.25 g or piperacillin/tazobactam 4.5 g every 6 h for 7-14 days. Initial doses were selected by CL... The modified ITT population comprised those with normal renal function (... Prescribing information-defined dose adjustments in participants with baseline RI and full dosing of imipenem/cilastatin/relebactam 1.25 g every 6 h for participants with normal renal function or augm...

Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.

To identify less invasive and easily applicable serum cytokine-derived biomarkers which contribute to the diagnostic utility and risk assessment ability of the prostate health index (PHI) based multiv... Serum 45 cytokines screening was performed in a small training cohort consisting of 10 sera by Luminex liquid array-based multiplexed immunoassays and identified TRAIL and IL-10 as new biomarkers for ... TRAIL and IL-10 were identified as potential serum biomarkers for AG PCa detection by the result of multi-cytokines screening in the univariate analysis, while multivariable logistic regression confir... We suggest a significant advantage for the PHI-based multivariate combinations of serum TRAIL and IL-10 comparing to PHI or other serum-derived biomarkers alone in the detection and risk stratificatio...

Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.

Switching from intravenous antibiotic therapy to oral antibiotic therapy among neonates is not yet practised in high-income settings due to uncertainties about exposure and safety. We aimed to assess ... In this multicentre, randomised, open-label, non-inferiority trial, patients were recruited at 17 hospitals in the Netherlands. Neonates (postmenstrual age ≥35 weeks, postnatal age 0-28 days, bodyweig... Between Feb 8, 2018 and May 12, 2021, 510 neonates were randomly assigned (n=255 oral amoxicillin-clavulanic group; n=255 intravenous antibiotic group). After excluding those who withdrew consent (n=4... An early intravenous-to-oral antibiotic switch with amoxicillin-clavulanic acid is non-inferior to a full course of intravenous antibiotics in neonates with probable bacterial infection and is not ass... The Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars, and the Sophia Foundation for Scientific Research....

'I probably wouldn't want to talk about anything too personal': A qualitative exploration of how issues of privacy, confidentiality and surveillance in the home impact on access and engagement with online services and spaces for care-experienced young people.

This paper draws on a qualitative interview-based study that explored online mental health and wellbeing interventions and services for care-experienced young people. The study involved young people (...

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

The risk and survival of patients with non-small cell lung cancer (NSCLC) with pre-existing autoimmune disorders (AIDs) receiving immune checkpoint blockade (ICB) therapy have not been clearly establi... This multi-institutional, retrospective cohort study was conducted in collaboration with 20 centers in Japan.... In total, 229 patients with advanced or recurrent NSCLC and pre-existing AID, with or without ICB treatment from January 2010-February 2020, were included and analyzed. Among 69 patients who received ... These findings revealed a novel risk factor for AID flares following ICB treatment, that is the diagnosis of NSCLC within 1 year of AID diagnosis, and showed that ICBs may improve survival in this pop...